艾伯特·霍夫曼第一次发现LSD时，将其记为 Lysergsäure-diäthylamid ，简写为LSD-25，指这是从麦角酸（ Lysergsäure ）衍生而来的第25种化合物。 现代德语写作 Lysergsäurediethylamid 。

[21] [19] LSD was the 25th of various lysergamides Hofmann synthesized from lysergic acid while trying to develop a new analeptic, hence the alternate name LSD-25. Hofmann discovered its effects in humans on April 16, in 1943, after unintentionally ingesting an unknown amount, possibly absorbing it through his skin.

Lysergic acid diethylamide (also known as Lysergide, LSD-25, LSD, L, Lucy, and Acid) is a classical psychedelic substance of the lysergamide class. It is perhaps the most researched and culturally influential psychedelic substance, as well as the prototypal lysergamide .

Nov 10, 2023 · LSD-25, otherwise called LSD or “corrosive,” has an intricate and storied history, set apart by its special consequences for cognizance and its true capacity for therapeutic applications.

Lysergic acid diethylamide (LSD-25 Sandoz) given orally in single doses as low as 20 micrograms produces depersonalization, derealization, and increased imagery in "normal" individuals. Larger doses are required to produce the same effect in psychotic patients.

In 1938, Swiss chemist Albert Hofmann (1906-2008) became the first person to synthesize and ingest LSD. 1 It was the twenty-fifth derivative he synthesized from the ergot fungus, hence its more proper name, LSD-25. LSD is the most potent psychedelic agent in humans. 2 It belongs to the ergoline family of psychedelic compounds, also called ...

The acute and the chronic psychotomimetic potentials of the hallucinogen lysergic acid diethylamide (LSD-25) have been recognized for almost 40 years. That additional types of the biological effects should have come under scrutiny was directly attributable to widespread use and abuse of this drug on …

LSD is the best known and most researched psychedelic. It is the standard against which all other psychedelics are compared. It is active at extremely low doses and is most commonly available on blotter or in liquid form. Since 2013, some blotter and liquid "acid" being sold in the Americas and Europe contains NBOMe compounds instead of LSD.

The great value of LSD-25 lies in the fact that when the therapeutic situation is properly structured the patient can, and often does, within a period of hours, develop a level of self-understanding and self-acceptance which may surpass that of the average

In 1947, Stoll 32 in Switzerland reported on the effects of D-lysergic acid diethylamide (LSD-25), an ergot derivative which can produce profound psychological effects in humans when it is given in minute doses. Since that time, a large volume of literature has grown up around this substance.